Five years together in the Women’s Race! And the journey shows. When we started, in 2022, only 3 out of every 10 Spaniards knew for sure what metastatic breast cancer is¹. Today, 93% of the population has heard of it². But the conversation about breast cancer is not complete without the M for metastatic, and there is still work to do.

That’s why this year, #laMquefalta is coming to the Madrid Women’s Race with a special ambassador. Patricia Ramírez joins the movement of the Spanish Metastatic Breast Cancer Association (AECMM), in collaboration with the Daiichi Sankyo | AstraZeneca Alliance, and will run with us to give metastatic breast cancer the visibility it deserves,

Do you want to be part of the movement?

1. Join us on May 10 at the Madrid Women’s Race.
2. Share your experience and support for #laMquefalta on social media tagging:

 @cancermamametastasico

 @daiichisankyo_es

 @astrazenecaes

3. The day after the Race, we encourage you to see how our ambassador experienced it @patri_psicóloga on her social media: (https://www.instagram.com/patri_psicologa/).
4. Leave your message of support with #LaMquefalta and share with your followers how it went and what this action means to you. A small gesture with real impact, because every comment helps ensure that the M, for metastatic, does not go unnoticed.

Join in and make it heard!

 

References

1. Survey “Knowledge about breast cancer among the Spanish population” conducted between February 15 and 17, 2022 by Atrevia and funded by the Daiichi Sankyo | AstraZeneca Alliance. Sample size of 5,024 units. 
2. Breast Cancer Awareness Survey in Europe by the Daiichi Sankyo | AstraZeneca Alliance. Conducted in October 2024 with 7,750 respondents in Germany, Spain, France, Italy and the United Kingdom.